Umeå University Hospital

Umeå SE-901 85

2 studies enrolling now · 12 studies all time

What they study most

Acute Myocardial Infarction, Amyloidogenic Transthyretin (ATTR) Amyloidosis, Amyotrophic Lateral Sclerosis, Brain Tumor, Coronary Artery Disease, FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome, Familial Pancreatic Cancer, Glioma, Malignant Melanoma, Pancreatic Ductal Adenocarcinoma, Prostate Cancer Recurrent, Renal Cell Carcinoma, Metastatic

Studies at this site

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• Transthyretin Amyloidosis Outcome Survey (THAOS) — Completed
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial — Stopped early
• Arimoclomol in Amyotropic Lateral Sclerosis — Completed
• Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) — Completed
• A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups — Completed
• Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Running, not enrolling
• Gliogene: Brain Tumor Linkage Study — Status unconfirmed
• A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis — Stopped early
• Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma — Completed